Published in Medical Letter on the CDC and FDA, February 16th, 2003
"Hence, in this study, we report the peptide-binding motifs of both molecules," stated Florence A. Castelli and collaborators at the Commissariat a l'Energie Atomique-Saclay, SEDAC Therapeutics, and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.